Date Posted
Consider attending these ASCO sessions to learn about the latest from the DCP symptom science and screening research programs, DCP-funded research from NCORP, and to hear from NCI Director W. Kimryn Rathmell, M.D., Ph.D.
Check out the full online program with session and on demand/on device links: https://meetings.asco.org/meetings/2024-asco-annual-meeting/316/program-guide/scheduled-sessions.
Scheduled Sessions
Saturday, June 1, 9:30 AM – 12:00 PM CDT
Title: Opening Session
Location: Hall B1 | Live Stream
The ASCO Opening Session features the ASCO President's Address, Presentation of the Fellows of the American Society of Clinical Oncology, and David A. Karnofsky Memorial Award and Lecture
Welcome and Introduction of Dr. Lynn M. Schuchter
Clifford A. Hudis, M.D., F.A.C.P., F.A.S.C.O. | ASCO
President's Address
Lynn M. Schuchter, M.D., F.A.S.C.O. | Perelman School of Medicine at the University of Pennsylvania
The Emergence of General Artificial Intelligence for Medicine
Jonathan M. Carlson, Ph.D. | Microsoft
The Art of Cancer Care
Abraham Verghese, M.D., M.A.C.P. | Stanford University
NCI Director's Remarks
W. Kimryn Rathmell, M.D., Ph.D., F.A.S.C.O. | National Cancer Institute
Presentation and Recognition of Conquer Cancer Top Donors
Howard A. Burris, M.D., F.A.C.P., F.A.S.C.O. | Sarah Cannon Research Institute
Presentation of Awards and the Fellows of the American Society of Clinical Oncology (FASCO)
Everett E. Vokes, M.D., F.A.S.C.O. | The University of Chicago
David Karnofsky Memorial Award and Lecture
Lillian L. Siu, M.D., F.R.C.P.C., F.A.S.C.O. | Princess Margaret Cancer Centre, University of Toronto
Saturday, June 1, 1:15 – 2:15 PM CDT
Session type: Education Session
Title: How and Where Will Public Investment Accelerate Progress in Oncology? A Discussion with the NIH and NCI Directors
Location: S100a | Live Stream
Welcome and Opening Remarks
Chair: Angela DeMichele, M.D., M.S.C.E., F.A.S.C.O. | University of Pennsylvania
Director of the National Institutes of Health
Monica M. Bertagnolli, M.D., F.A.C.S., F.A.S.C.O. | National Institutes of Health
Director of the National Cancer Institute
W. Kimryn Rathmell, M.D., Ph.D., F.A.S.C.O. | National Cancer Institute
Monday June 3, 1:30 PM CDT
Session type: Poster Session
Primary Track: Symptom Science and Palliative Care
Location: Hall A/On Demand
Title: Chemotherapy-induced peripheral neuropathy research: A National Institute of Health (NIH) grant portfolio analysis.
Presenter: Rachel Altshuler, Ph.D. | National Cancer Institute
Abstract: 12064 | Poster Bd #: 193
Monday June 3, 1:30 PM CDT
Session type: Poster Session
Primary Track: Prevention, Risk Reduction, and Genetics
Location: Hall A/On Demand
Title: Perceptions of non-disclosure of results in clinical trial designs for multicancer detection tests.
Presenter: (Sarah Temkin, O.R.W.H.) Goli Samimi, Ph.D., M.P.H. | Division of Cancer Prevention, National Cancer Institute at the National Institutes of Health
Abstract: 10546 | Poster Bd #: 73
NCORP Abstracts
Saturday, June 1, 9:00 AM CDT
Session Type: Poster Session
Primary Track: Care Delivery and Quality Care
Location: Hall A | On Demand
Title: Importance of information-seeking styles among patients with cancer pre- and post-treatment: A URCC NCORP Research Base study.
Presenter: Sule Yilmaz, Ph.D., University of Rochester Medical Center, Abstract 1527 | Poster Bd 398
Sunday, June 2, 8:00 – 11:00 AM CDT
Session Type: Oral Abstract Session
Primary Track: Symptom Science and Palliative Care
Location: S100a | Live Stream
9:12 AM CDT
Title: Alliance A222001: A randomized, double-blind, placebo controlled phase II study of oxybutynin versus placebo for the treatment of hot flashes in men receiving androgen deprivation therapy.
Presenter: Brad J. Stish, M.D., Mayo Clinic Department of Radiation Oncology, Abstract LBA12004
9:24 AM CDT
Title: Risk prediction model for taxane-induced peripheral neuropathy (TIPN) in patients with early-stage cancer receiving taxane therapy: SWOG S1714.
Presenter: Meghna S. Trivedi, M.D., M.S., Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, Abstract 12005
10:24 AM CDT
Title: Walking dose required to achieve a clinically meaningful reduction in cancer-related fatigue among patients with breast cancer receiving chemotherapy: A URCC NCORP nationwide prospective cohort study.
Presenter: Lindsey Jean Mattick, Ph.D., James P. Wilmot Cancer Center, University of Rochester Medical Center, Abstract 12008
Monday, June 3, 8:00 – 11:00 AM CDT
Session Type: Oral Abstract Session
Primary Track: Genitourinary Cancer – Kidney and Bladder
Location: Hall B1 | Live Stream
8:00 AM CDT
Title: Effects of immune-enhancing nutrition on radical cystectomy outcomes: Primary results from the randomized phase III double-blind clinical trial (S1600).
Presenter: Jill Hamilton-Reeves, Ph.D., R.D., University of Kansas Medical Center, Abstract 4501
Monday, June 3, 9:00 AM CDT
Session Type: Poster Session
Primary Track: Hematologic Malignancies
Location: Hall A | On Demand
Title: Longitudinal patterns of patient-reported cognitive impairment in patients with non-Hodgkin lymphoma (NHL) treated with chemotherapy: A group-based trajectory analysis of a nationwide community-based cohort.
Presenter: Tianming Zhao, M.B., M.S., University of Rochester Medical Center, Abstract 7071 | Poster Bd 54
Session Type: Poster Session
Primary Track: Care Delivery and Quality Care
Location: Hall A | On Demand
Title: Risk prediction model for acute care use among patients with advanced cancer on clinical trials.
Presenter: Dawn L. Hershman, M.D., M.S., F.A.S.C.O., Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, Abstract 11074 | Poster Bd 269
Session Type: Poster Session
Primary Track: Care Delivery and Quality Care
Location: Hall A | On Demand
Title: If you build it, they will come: Success of the EROS (Engendering Reproductive Health Within Oncologic Survivorship)—ECOG-ACRIN E1Q11 in recruitment of minority patients. Presenter: Ashlesha Patel, Cook County Hospital, Abstract 11124 | Poster Bd 319
Monday, June 3, 9:45 – 11:15 AM CDT
Session Type: Rapid Oral Abstract Session
Primary Track: Symptom Science and Palliative Care
Location: S102 | On Demand
10:15 AM CDT
Title: The influence of yoga and cognitive behavioral therapy on mediational relationships between insomnia and cancer-related fatigue: A URCC NCORP RCT in 550 cancer survivors.
Presenter: Po-Ju Lin, Ph.D., R.D., M.P.H., James P. Wilmot Cancer Center, University of Rochester Medical Center, Abstract 12015
Monday, June 3, 1:15 – 2:45 PM CDT
Session Type: Rapid Oral Abstract Session
Primary Track: Care Delivery and Quality Care
Location: S102 | On Demand
2:15 PM CDT
Title: Patient-reported fatigue and risk of treatment-related adverse events (AEs) in patients receiving systemic therapy in cancer clinical trials.
Presenter: Joseph M. Unger, Ph.D., M.S., SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Abstract 11015
Monday, June 3, 3:00 – 6:00 PM CDT
Session Type: Oral Abstract Session
Primary Track: Breast Cancer
Location: Hall B1 | Live Stream
4:00 PM CDT
Title: ECOG-ACRIN EAZ171: Prospective validation trial of germline variants and taxane type in association with taxane-induced peripheral neuropathy (TIPN) in Black women with early-stage breast cancer.
Presenter: Tarah Jean Ballinger, M.D., Indiana University Simon Comprehensive Cancer Center, Abstract LBA503
Monday, June 3, 4:30 PM CDT
Session Type: Clinical Science Symposium – The Art and Science of Hope
Primary Track: Symptom Science and Palliative Care
Location: S100a | Live Stream
5:18 PM CDT
Title: Hope drives quality of life in patients with brain metastases, but the hope center remains elusive: An analysis of NRG-CC003.
Presenter: Benjamin W. Corn, M.D., Sharei Zedek Hospital, Abstract 12011